David Grainger
Equibles does not estimate personal net worth.
About David Grainger
The proxy statement of Centessa Pharmaceuticals plc reports total compensation of $1,363,599 for David Grainger in fiscal 2023, including a base salary of $520,612. Disclosed compensation is on record for 2 fiscal years.
Affiliation history
-
Centessa Pharmaceuticals plc (CNTA)
Proxy statement
Start not stated–2024-01-01
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Centessa Pharmaceuticals plc (CNTA) | Former Chief Innovation Officer | $520,612 | $1,363,599 |
| 2022 | Centessa Pharmaceuticals plc (CNTA) | Former Chief Innovation Officer | $464,069 | $2,447,805 |
Recent activity
No call appearances or filed executive changes recorded yet.